Publications by authors named "Edward D Ball"

55Publications

Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?

Clin Med Insights Oncol 2020 28;14:1179554920976366. Epub 2020 Dec 28.

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.

View Article and Find Full Text PDF
December 2020

Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults.

Expert Opin Biol Ther 2020 Oct 5:1-14. Epub 2020 Oct 5.

Department of Medicine, Division of Blood and Marrow Transplantation, University of California , San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
October 2020

MHC-I genotype and tumor mutational burden predict response to immunotherapy.

Genome Med 2020 05 19;12(1):45. Epub 2020 May 19.

Division of Hematology/Oncology Center for Personalized Cancer Therapy, Department of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.

View Article and Find Full Text PDF
May 2020

Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2020 Jul 21;20(7):431-437.e2. Epub 2019 Oct 21.

Department of Medicine, Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, CA.

View Article and Find Full Text PDF
July 2020

Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation.

Hum Immunol 2018 Dec 11;79(12):848-854. Epub 2018 Oct 11.

Department of Pathology, University of California San Diego, La Jolla, CA, USA. Electronic address:

View Article and Find Full Text PDF
December 2018

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2018 05 2;18(5):346-352.e5. Epub 2018 Mar 2.

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego, Moores Cancer Center, La Jolla, CA. Electronic address:

View Article and Find Full Text PDF
May 2018

Proinflammatory Dual Receptor T Cells in Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2017 Nov 24;23(11):1852-1860. Epub 2017 Jul 24.

Department of Pathology, University of California San Diego, La Jolla, California. Electronic address:

View Article and Find Full Text PDF
November 2017

What are the latest advancements in acute myeloid leukemia therapy?

Future Oncol 2017 Apr 27;13(10):867-871. Epub 2017 Feb 27.

Department of Medicine, Division of Blood & Marrow Transplantation, University of California, San Diego Moores Cancer Center, San Diego, CA, USA.

View Article and Find Full Text PDF
April 2017

CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.

Cancer Cell 2016 Nov 27;30(5):792-805. Epub 2016 Oct 27.

Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA 92093, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA; Moores Cancer Center, University of California San Diego School of Medicine, La Jolla, CA 92093, USA; Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA 92093, USA. Electronic address:

View Article and Find Full Text PDF
November 2016

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.

Cell Stem Cell 2016 11 25;19(5):599-612. Epub 2016 Aug 25.

Division of Regenerative Medicine, Moores Cancer Center, and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address:

View Article and Find Full Text PDF
November 2016

Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

N Engl J Med 2016 Jul;375(2):143-53

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School (M.S.D., H.T.K., P.B., R.L., A.S., A.P.L., M.H., M.S., F.S.H., C.J.W., V.T.H., C. Cutler, J.K., E.P.A., J.H.A., P.A., J.R., R.J.S.), the Bone Marrow Transplant Program, Beth Israel Deaconess Medical Center and Harvard Medical School (D.A.), the Bone Marrow Transplant Program, Massachusetts General Hospital Cancer Center and Harvard Medical School (Y.-B.C.), the Departments of Dermatology (N.R.L.) and Pathology (S.R.G., J.L.H., S.J.R.), Dana-Farber and Brigham and Women's Cancer Center, and the Dana-Farber Cancer Institute, Center for Molecular Oncologic Pathology (M.B., C.W.Z.) - all in Boston; Broad Institute of Massachusetts Institute of Technology and Harvard (P.B., C.J.W.) and Neon Therapeutics (M.S.R.) - both in Cambridge; the Blood and Marrow Transplant Program, University of California, San Diego, Moores Cancer Center, La Jolla (C. Costello, E.D.B.); Colorado Blood Cancer Institute, Denver (P.M.); Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (H.S.); and the Blood and Marrow Transplant Group of Georgia at Northside Hospital, Atlanta (A.B.).

View Article and Find Full Text PDF
July 2016

Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.

Cancer Immunol Immunother 2015 Jun 21;64(6):737-44. Epub 2015 Mar 21.

Division of Blood and Marrow Transplantation, Departments of Medicine, Pathology and the Moores UCSD Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92093-0960, USA.

View Article and Find Full Text PDF
June 2015

A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfall.

Int J Clin Exp Pathol 2014 15;7(1):378-85. Epub 2013 Dec 15.

Department of Pathology, University of California San Diego Health System La Jolla, CA 92093-0987.

View Article and Find Full Text PDF
September 2014

Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.

Transfusion 2014 Jul 24;54(7):1857-63. Epub 2013 Dec 24.

Research Service and Division of Nephrology-Hypertension, Veterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, California; Department of Medicine, Pathology and Moore's Cancer Center, University of California at San Diego, La Jolla, California.

View Article and Find Full Text PDF
July 2014

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.

J Clin Oncol 2013 Nov 14;31(33):4199-206. Epub 2013 Oct 14.

Philippe Armand and Edie Weller, Dana-Farber Cancer Institute; David E. Avigan, Beth Israel Deaconess Medical Center; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Arnon Nagler, Chaim Sheba Medical Center, Tel-Hashomer; Reuven Or, Hadassah Medical Center, Jerusalem; Rinat Rotem-Yehudar, CureTech, Yavne, Israel; Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus; Hillard M. Lazarus, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH; Mark S. Kaminski, University of Michigan, Ann Arbor, MI; H. Kent Holland, Northside Hospital; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine; Stephanie A. Gregory, Rush Medical Center, Chicago, IL; James R. Mason, Scripps Clinic; Edward D. Ball, Moores University of California at San Diego Cancer Center, University of California, San Diego; John M. Timmerman and David Andorsky, University of California, Los Angeles, Los Angeles, CA; Joseph W. Fay, Baylor Research Institute, Baylor University Medical Center, Dallas; Chitra M. Hosing, The University of Texas MD Anderson Cancer Center, Houston, TX; David A. Rizzieri, Duke Cancer Center, Durham, NC; Joseph P. Uberti, Karmanos Cancer Institute, Detroit, MI; Markus Y. Mapara, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA.

View Article and Find Full Text PDF
November 2013

Plerixafor as first- and second-line strategies for autologous stem cell mobilization in patients with non-Hodgkin's lymphoma or multiple myeloma.

Pharmacotherapy 2012 Jul;32(7):596-603

Department of Pharmacy, University of California San Diego Medical Center, San Diego, CA 92103-8765, USA.

View Article and Find Full Text PDF
July 2012

Idiotype immunization following high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma.

Biol Blood Marrow Transplant 2012 Feb 4;18(2):257-64. Epub 2011 Jul 4.

Moores UCSD Cancer Center, Blood and Marrow Transplantation Division, University of California-San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA.

View Article and Find Full Text PDF
February 2012

Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies.

Support Care Cancer 2011 Dec 30;19(12):2015-20. Epub 2010 Nov 30.

Department of Psychiatry, University of California, San Diego, San Diego, USA.

View Article and Find Full Text PDF
December 2011

Monoclonal antibodies in the treatment of hematologic malignancy.

Best Pract Res Clin Haematol 2010 Sep 12;23(3):403-16. Epub 2010 Aug 12.

University of California San Diego Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093-0960, USA.

View Article and Find Full Text PDF
September 2010

Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences.

Biol Blood Marrow Transplant 2011 Apr 11;17(4):566-73. Epub 2010 Aug 11.

Department of Medicine, Oregon Health & Science University, Portland, OR, USA.

View Article and Find Full Text PDF
April 2011

Toxicity-evaluation designs for phase I/II cancer immunotherapy trials.

Stat Med 2010 Mar;29(7-8):712-20

Division of Biostatistics, Moores UCSD Cancer Center, University of California, La Jolla, CA 92093-0901, USA.

View Article and Find Full Text PDF
March 2010

Increasing the punch of reduced-intensity transplants.

Authors:
Edward D Ball

Blood 2009 Dec;114(27):5410-1

University Of California, San Diego, CA, USA.

View Article and Find Full Text PDF
December 2009

Review and revision of clinical practice of using G-CSF after autologous and allogeneic hematopoietic stem cell transplantation at UCSD.

J Oncol Pharm Pract 2011 Jun 16;17(2):85-90. Epub 2009 Dec 16.

University of California, San Diego Medical Center, La Jolla, CA 92093-0960, USA

View Article and Find Full Text PDF
June 2011

Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.

Exp Hematol 2008 Apr 30;36(4):486-94. Epub 2008 Jan 30.

Departments of Medicine and the Moores UCSD Cancer Center, University of California San Diego, La Jolla, Calif. 92093-0960, USA.

View Article and Find Full Text PDF
April 2008

Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.

Exp Hematol 2006 Jun;34(6):728-35

Glycobiology Research and Training Center, University of California, San Diego, La Jolla, USA.

View Article and Find Full Text PDF
June 2006

Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.

Clin Cancer Res 2006 Apr;12(7 Pt 1):2224-31

Division of Blood and Marrow Transplantation, Department of Medicine and Moores University of California at San Diego Cancer Center, University of California San Diego, La Jolla, California, USA.

View Article and Find Full Text PDF
April 2006

Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.

Exp Hematol 2005 Feb;33(2):199-211

Department of Medicine and Moores UCSD Cancer Center, University of California, San Diego, La Jolla, Calif, USA.

View Article and Find Full Text PDF
February 2005

Targeting gastrin-releasing peptide receptors for cancer treatment.

Anticancer Drugs 2004 Nov;15(10):921-7

Division of Blood and Marrow Transplantation, Department of Medicine and Moores UCSD Cancer Center, University of California San Diego, La Jolla, CA 92093-0960, USA.

View Article and Find Full Text PDF
November 2004

Summary of the 12th international symposium on recent advances in stem cell transplantation.

Exp Hematol 2004 Oct;32(10):881-4

University of California San Diego Cancer Center, La Jolla, Calif. 92093-0960, USA.

View Article and Find Full Text PDF
October 2004

Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodies.

Leuk Res 2004 Aug;28(8):821-9

Department of Medicine and Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA, USA.

View Article and Find Full Text PDF
August 2004

Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells.

Exp Hematol 2004 May;32(5):470-5

Division of Blood and Marrow Transplantation, Department of Medicine, and Moores UCSD Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.

View Article and Find Full Text PDF
May 2004

Update in hematology.

Authors:
Edward D Ball

Ann Intern Med 2003 Dec;139(11):916-22

Division of Blood and Bone Marrow Transplantation, University of California, San Diego, San Diego, California 92093-0960, USA.

View Article and Find Full Text PDF
December 2003

Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.

Clin Cancer Res 2003 Oct;9(13):4953-60

Division of Blood and Marrow Transplantation, Department of Medicine, University of California San Diego, La Jolla, California 92093-0960, USA.

View Article and Find Full Text PDF
October 2003

The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression.

Exp Hematol 2003 May;31(5):363-71

Department of Medicine and Cancer Center, University of California, San Diego School of Medicine, La Jolla, Calif., USA.

View Article and Find Full Text PDF
May 2003

Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia.

Biol Blood Marrow Transplant 2002 ;8(10):557-68

Department of Medicine and Cancer Center, University of California San Diego, La Jolla 93093-0906, USA.

View Article and Find Full Text PDF
July 2003

Development of allogeneic hematopoietic stem cell transplantation (HSCT).

Cancer Treat Res 2002 ;110:1-37

Hematology/Oncology Division, University of California San Diego, Department of Medicine, San Diego, CA 94103, USA.

View Article and Find Full Text PDF
August 2002